Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

[Importance of the time for stopping the combined use of aspirin and clopidogrel in patients undergoing coronary artery by-pass graft surgery].

Leiva-Pons JL, Carrillo-Calvillo J, Leiva-Garza JL, Loyo-Olivo MA, Piãa-Ramírez BM, López-Quijano JM, Celaya-Lara S, Cerda-Alanís R, Guerrero H.

Arch Cardiol Mex. 2008 Apr-Jun;78(2):178-86. Spanish.

PMID:
18754409
2.

Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.

Kulik A, Chan V, Ruel M.

Expert Opin Drug Saf. 2009 Mar;8(2):169-82. doi: 10.1517/14740330902797081 . Review.

PMID:
19309245
3.

Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients.

Patel JH, Stoner JA, Owora A, Mathew ST, Thadani U.

Am J Cardiol. 2009 Jun 15;103(12):1687-93. doi: 10.1016/j.amjcard.2009.02.021. Epub 2009 May 4. Review.

PMID:
19539077
4.

Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery.

Cannon CP, Mehta SR, Aranki SF.

Ann Thorac Surg. 2005 Aug;80(2):768-79. Review.

PMID:
16039260
5.

Dual antiplatelet therapy with clopidogrel and aspirin.

Sullivan J, Amarshi N.

Am J Health Syst Pharm. 2008 Jun 15;65(12):1134-43. doi: 10.2146/ajhp060662. Review.

PMID:
18541683
6.

Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.

Zimmermann N, Gams E, Hohlfeld T.

Eur J Cardiothorac Surg. 2008 Jul;34(1):93-108. doi: 10.1016/j.ejcts.2008.03.023. Epub 2008 Apr 29. Review.

PMID:
18448350
7.

Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit?

Collet JP, Montalescot G.

Int J Cardiol. 2009 Mar 20;133(1):8-17. doi: 10.1016/j.ijcard.2008.12.202. Epub 2009 Feb 1. Review.

PMID:
19187982
8.

Use of aspirin and clopidogrel after coronary artery bypass graft surgery.

de Leon N, Jackevicius CA.

Ann Pharmacother. 2012 May;46(5):678-87. doi: 10.1345/aph.1Q692. Epub 2012 May 8. Review.

PMID:
22570427
9.

Variability in responsiveness to oral antiplatelet therapy.

Angiolillo DJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):27A-34A. doi: 10.1016/j.amjcard.2008.11.020. Review.

PMID:
19166710
10.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
11.

Platelet-directed therapies and coronary artery bypass grafting.

Berger JS.

Am J Cardiol. 2009 Sep 7;104(5 Suppl):44C-8C. doi: 10.1016/j.amjcard.2009.06.015. Review.

PMID:
19695361
12.

Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting.

Pickard AS, Becker RC, Schumock GT, Frye CB.

Pharmacotherapy. 2008 Mar;28(3):376-92. doi: 10.1592/phco.28.3.376. Review.

PMID:
18294117
13.

Unmet needs in oral antiplatelet therapy with ADP receptor blocking agents.

Husted S.

Fundam Clin Pharmacol. 2009 Feb;23(1):1-9. doi: 10.1111/j.1472-8206.2008.00660.x. Review.

PMID:
19267766
14.

Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?

Bakhru MR, Bhatt DL.

Cleve Clin J Med. 2008 Apr;75(4):289-95. Review.

PMID:
18491435
15.

Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery.

Mahla E, Metzler H, Tantry US, Gurbel PA.

Ann Thorac Surg. 2010 Sep;90(3):1040-51. doi: 10.1016/j.athoracsur.2010.04.041. Review.

PMID:
20732553
16.

Identification of and management approaches for the high-risk patient.

Bhatt DL.

Am J Cardiol. 2006 Dec 18;98(12A):22Q-29Q. Epub 2006 Oct 23. Review.

PMID:
17169626
17.

Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.

Lordkipanidzé M, Diodati JG, Pharand C.

Pharmacol Ther. 2009 Aug;123(2):178-86. doi: 10.1016/j.pharmthera.2009.03.019. Epub 2009 May 6. Review.

PMID:
19426760
18.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
19.

An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.

Terpening C.

J Am Board Fam Med. 2009 Jan-Feb;22(1):51-6. doi: 10.3122/jabfm.2009.01.070282. Review.

20.

Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.

Bhatt DL.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):11A-19A. doi: 10.1016/j.amjcard.2008.11.018. Review.

PMID:
19166708

Supplemental Content

Support Center